Advances in tissue engineering for the repair of growth plate injuries.

IF 4.8 3区 工程技术 Q1 BIOTECHNOLOGY & APPLIED MICROBIOLOGY
Frontiers in Bioengineering and Biotechnology Pub Date : 2025-09-16 eCollection Date: 2025-01-01 DOI:10.3389/fbioe.2025.1608923
Wenla Wang, Wenxiang Zeng, Qingyu Tu, Qing Li, Jindi Xu, Wei Zhuang
{"title":"Advances in tissue engineering for the repair of growth plate injuries.","authors":"Wenla Wang, Wenxiang Zeng, Qingyu Tu, Qing Li, Jindi Xu, Wei Zhuang","doi":"10.3389/fbioe.2025.1608923","DOIUrl":null,"url":null,"abstract":"<p><p>The growth plate is a cartilage tissue located between the epiphysis and diaphysis of long bones, responsible for the longitudinal growth of the skeleton. Due to its limited regenerative capacity, when the growth plate is damaged, it is typically replaced by inappropriate bone tissue, leading to the formation of bony bridges. These bony bridges not only restrict normal skeletal growth but may also cause limb length discrepancies, angular deformities, and functional impairments. Although traditional clinical treatments have shown some effectiveness, they are often associated with severe complications and poor prognoses. Therefore, the development of effective therapeutic strategies to prevent the formation of bony bridges and promote the repair and regeneration of the growth plate has become a current research focus. Cartilage tissue engineering, as an emerging therapeutic approach, restore the function of the growth plate through the substitution or repair of damaged cartilage tissue, has been widely applied in the repair of growth plate injuries. Cartilage tissue engineering for growth plate injury primarily relies on three key components: seed cells, growth factors, and scaffold materials. Seed cells provide the basis for cartilage regeneration, typically using autologous or allogeneic chondrocytes, mesenchymal stem cells, etc.,; growth factors such as bone morphogenetic proteins (BMPs) and transforming growth factor-beta (TGF-β) promote cell proliferation and differentiation, while regulating the synthesis of cartilage matrix; scaffold materials provide three-dimensional structural support, offering a platform for directed cell growth and tissue repair. In recent years, with continuous advancements in biomaterials and innovations in tissue engineering techniques, cartilage tissue engineering has shown promising prospects for application. This article systematically reviews the latest research progress on cartilage tissue engineering in the repair of growth plate injuries, based on a comprehensive search and analysis of relevant literature from databases such as PubMed and CNKI. The paper focuses on the classification and stages of growth plate injuries and discusses the three essential elements of tissue engineering treatment for growth plate injury.</p>","PeriodicalId":12444,"journal":{"name":"Frontiers in Bioengineering and Biotechnology","volume":"13 ","pages":"1608923"},"PeriodicalIF":4.8000,"publicationDate":"2025-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479520/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Bioengineering and Biotechnology","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.3389/fbioe.2025.1608923","RegionNum":3,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The growth plate is a cartilage tissue located between the epiphysis and diaphysis of long bones, responsible for the longitudinal growth of the skeleton. Due to its limited regenerative capacity, when the growth plate is damaged, it is typically replaced by inappropriate bone tissue, leading to the formation of bony bridges. These bony bridges not only restrict normal skeletal growth but may also cause limb length discrepancies, angular deformities, and functional impairments. Although traditional clinical treatments have shown some effectiveness, they are often associated with severe complications and poor prognoses. Therefore, the development of effective therapeutic strategies to prevent the formation of bony bridges and promote the repair and regeneration of the growth plate has become a current research focus. Cartilage tissue engineering, as an emerging therapeutic approach, restore the function of the growth plate through the substitution or repair of damaged cartilage tissue, has been widely applied in the repair of growth plate injuries. Cartilage tissue engineering for growth plate injury primarily relies on three key components: seed cells, growth factors, and scaffold materials. Seed cells provide the basis for cartilage regeneration, typically using autologous or allogeneic chondrocytes, mesenchymal stem cells, etc.,; growth factors such as bone morphogenetic proteins (BMPs) and transforming growth factor-beta (TGF-β) promote cell proliferation and differentiation, while regulating the synthesis of cartilage matrix; scaffold materials provide three-dimensional structural support, offering a platform for directed cell growth and tissue repair. In recent years, with continuous advancements in biomaterials and innovations in tissue engineering techniques, cartilage tissue engineering has shown promising prospects for application. This article systematically reviews the latest research progress on cartilage tissue engineering in the repair of growth plate injuries, based on a comprehensive search and analysis of relevant literature from databases such as PubMed and CNKI. The paper focuses on the classification and stages of growth plate injuries and discusses the three essential elements of tissue engineering treatment for growth plate injury.

Abstract Image

Abstract Image

Abstract Image

生长板损伤修复的组织工程研究进展。
生长板是位于骨骺和长骨骨干之间的软骨组织,负责骨骼的纵向生长。由于其有限的再生能力,当生长板受损时,通常会被不合适的骨组织取代,导致骨桥的形成。这些骨桥不仅限制了正常的骨骼生长,还可能导致肢体长度差异、角度畸形和功能障碍。虽然传统的临床治疗已显示出一定的效果,但它们往往伴有严重的并发症和预后不良。因此,开发有效的治疗策略来防止骨桥的形成,促进生长板的修复和再生已成为当前的研究热点。软骨组织工程作为一种新兴的治疗方法,通过替代或修复受损的软骨组织来恢复生长板的功能,在生长板损伤的修复中得到了广泛的应用。软骨组织工程用于生长板损伤主要依赖于三个关键组成部分:种子细胞、生长因子和支架材料。种子细胞为软骨再生提供了基础,通常使用自体或异体软骨细胞、间充质干细胞等;骨形态发生蛋白(BMPs)和转化生长因子-β (TGF-β)等生长因子促进细胞增殖和分化,同时调节软骨基质的合成;支架材料提供三维结构支撑,为定向细胞生长和组织修复提供平台。近年来,随着生物材料的不断进步和组织工程技术的不断创新,软骨组织工程显示出了广阔的应用前景。本文通过对PubMed、CNKI等数据库相关文献的综合检索和分析,系统综述了软骨组织工程在生长板损伤修复中的最新研究进展。本文重点介绍了生长板损伤的分类和分期,并讨论了组织工程治疗生长板损伤的三个基本要素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Frontiers in Bioengineering and Biotechnology
Frontiers in Bioengineering and Biotechnology Chemical Engineering-Bioengineering
CiteScore
8.30
自引率
5.30%
发文量
2270
审稿时长
12 weeks
期刊介绍: The translation of new discoveries in medicine to clinical routine has never been easy. During the second half of the last century, thanks to the progress in chemistry, biochemistry and pharmacology, we have seen the development and the application of a large number of drugs and devices aimed at the treatment of symptoms, blocking unwanted pathways and, in the case of infectious diseases, fighting the micro-organisms responsible. However, we are facing, today, a dramatic change in the therapeutic approach to pathologies and diseases. Indeed, the challenge of the present and the next decade is to fully restore the physiological status of the diseased organism and to completely regenerate tissue and organs when they are so seriously affected that treatments cannot be limited to the repression of symptoms or to the repair of damage. This is being made possible thanks to the major developments made in basic cell and molecular biology, including stem cell science, growth factor delivery, gene isolation and transfection, the advances in bioengineering and nanotechnology, including development of new biomaterials, biofabrication technologies and use of bioreactors, and the big improvements in diagnostic tools and imaging of cells, tissues and organs. In today`s world, an enhancement of communication between multidisciplinary experts, together with the promotion of joint projects and close collaborations among scientists, engineers, industry people, regulatory agencies and physicians are absolute requirements for the success of any attempt to develop and clinically apply a new biological therapy or an innovative device involving the collective use of biomaterials, cells and/or bioactive molecules. “Frontiers in Bioengineering and Biotechnology” aspires to be a forum for all people involved in the process by bridging the gap too often existing between a discovery in the basic sciences and its clinical application.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信